Supreme Court Is Wary Of Healthcare Provider Suits Alleging Overpricing By Pharma
This article was originally published in The Pink Sheet Daily
Executive Summary
During oral arguments in Astra v. Santa Clara County, justices seemed to back pharma's position that 340B entities do not have the right to sue drug makers for violating price ceilings in government contracts.
You may also be interested in...
Rx Pricing At The High Court: Justices Friendlier To Enforcement From States Than 340B Entities
U.S. Supreme Court justices’ skepticism over the right of 340B entities to sue pharmaceutical companies for overcharges does not appear to extend to states’ ability to challenge drug prices reported under Medicaid.
Rx Pricing At The High Court: Justices Friendlier To Enforcement From States Than 340B Entities
U.S. Supreme Court justices’ skepticism over the right of 340B entities to sue pharmaceutical companies for overcharges does not appear to extend to states’ ability to challenge drug prices reported under Medicaid.
Supreme Rx: 340B Pricing, Baycol Class Action To Get High Court Review
The court will consider whether health care providers have the right to file suit to get drug manufacturers to enforce statutory requirements on drug pricing.